Logo

Similar Products

Description

Amoxapine USP is a premium-grade tricyclic antidepressant active pharmaceutical ingredient belonging to the dibenzoxazepine class. Manufactured under strict quality control standar...
Amoxapine USP is a premium-grade tricyclic antidepressant active pharmaceutical ingredient belonging to the dibenzoxazepine class. Manufactured under strict quality control standards, this compound works by affecting neurotransmitters in the brain that become unbalanced during depressive episodes. Its chemical structure ensures effective absorption and consistent performance in final pharmaceutical products. As a USP-grade material, it meets rigorous purity and composition standards required for pharmaceutical manufacturing, making it ideal for companies producing reliable mental health medications. The product's stability and compatibility with various formulations make it a preferred choice for drug manufacturers worldwide seeking consistent raw materials for their production processes.

This API is extensively used in the pharmaceutical industry for developing medications that treat depression, anxiety disorders, and panic attacks. Mental health facilities, hospitals, and psychiatric clinics rely on amoxapine-based medications as part of their treatment protocols. The manufacturing sector values its consistent quality for producing both generic and branded antidepressants. Distributors and wholesalers supply this ingredient to formulation companies across multiple markets, ensuring availability of essential mental health treatments globally. Its applications extend to veterinary medicine in some regions, demonstrating versatility across healthcare segments while maintaining therapeutic effectiveness.

Businesses choosing our Amoxapine USP benefit from unmatched reliability and supply chain consistency. Our product undergoes multiple quality checks throughout manufacturing, ensuring batch-to-batch consistency that pharmaceutical companies require. This reliability translates to reduced production delays and consistent end-product quality, ultimately protecting brand reputation and patient safety. Long-term partnerships with global suppliers ensure stable pricing and availability, even during market fluctuations, providing manufacturers with the confidence needed for continuous production planning and market supply commitments.

Key Features:
- USP-grade purity ensuring pharmaceutical standards compliance
- Tricyclic dibenzoxazepine class antidepressant with proven efficacy
- Stable chemical structure suitable for various formulation types
- Batch-to-batch consistency verified through rigorous quality control
- High bioavailability and optimal absorption characteristics

Benefits:
- Consistent therapeutic performance in final medication formulations
- Reduced production delays through reliable supply chain management
- Enhanced patient safety through rigorous quality assurance processes
- Compatibility with standard pharmaceutical manufacturing equipment
- Trusted ingredient for developing effective mental health treatments

Specifications

Additional Information
Country of OriginIndia
CustomisableNo

Application

Amoxapine USP is primarily formulated into oral tablets and capsules for psychiatric treatments. Its chemical stability and bioavailability make it suitable for extended-release formulations, ensuring consistent therapeutic delivery for patients requiring long-term depression management. Pharmaceutical manufacturers value its compatibility with standard excipients and production processes, allowing efficient integration into existing production lines without major reformulation needs.

This active pharmaceutical ingredient is essential for producing medications that address major depressive disorders, generalized anxiety, and panic attacks. It is also utilized in combination therapies where complementary mechanisms enhance overall treatment efficacy. Hospitals, mental health clinics, and retail pharmacies stock amoxapine-based medicines as frontline treatments, making it a critical component for healthcare providers aiming to offer comprehensive mental health solutions.
- Manufacturing antidepressant tablets for major depressive disorder treatment
- Producing anti-anxiety medications for generalized anxiety disorder management
- Formulating panic disorder relief drugs for emergency and routine care
- Developing combination therapies with other psychiatric medications for enhanced efficacy
- Supplying bulk API to compounding pharmacies for customized patient-specific formulations

Trade Details

Available StockIn stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Cash on Delivery (COD, if applicable)

Company Profile

Mehta Pharmaceutical Industries, Maharashtra
Verified
IndiaMaharashtra, India
ManufacturerImporter / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Amoxapine USP API For Depression Anxiety Panic Disorder Treatment

Amoxapine USP API is a high-purity tricyclic antidepressant active pharmaceutical ingredient for manufacturing depression, anxiety, and panic disorder medications with reliable quality and proven efficacy.

Min. Order Quantity: 1 units

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Mehta Pharmaceutical Industries
Verified
IndiaMaharashtra, India
Manufacturer

More Products From Supplier

Related Products